Cartesian Therapeutics (RNAC) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist

19.020
-0.250-1.30%

Close Dec 20 16:00 ET

19.020
-0.0010.00%

Post 16:30 ET

483.39MMarket Cap-0.41P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

BTIG Initiates Cartesian Therapeutics(RNAC.US) With Buy Rating, Announces Target Price $42
Moomoo NewsDec 20 13:43 ET · Ratings
Cartesian Therapeutics Price Target Announced at $42.00/Share by BTIG
Dow JonesDec 19 12:56 ET · Ratings
Cartesian Therapeutics Analyst Ratings
BenzingaDec 19 12:45 ET · Ratings
Revenues Not Telling The Story For Cartesian Therapeutics, Inc. (NASDAQ:RNAC)
Simply Wall StDec 18 08:04 ET
Cartesian Therapeutics Announces New Employment Inducement Grants
GlobeNewswireDec 18 07:05 ET
Express News | Cartesian Therapeutics Files For Proposed Resale Or Other Disposition By Selling Stockholders Of Up To 6.3M Common Stock
BenzingaDec 13 16:18 ET

Comments

Jaguar8

Sep 9 06:32

NEWS

$Cartesian Therapeutics (RNAC.US)$
Cartesian Therapeutics Gets FDA Rare Pediatric Disease Designation for Dermatomyositis Treatment

Trytosaveabit

Jul 2 05:31

News

$Cartesian Therapeutics (RNAC.US)$ Press Release: Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing
Dow Jones· just

Trytosaveabit

Apr 10 15:53

Update! With 2 new 13D

$Cartesian Therapeutics (RNAC.US)$Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.
SEC announcement
13 mins ago
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals...

God(S) is Stonk

Mar 27 13:59

RNAC 👀

$Cartesian Therapeutics (RNAC.US)$ did no one notice springer just bought another 1.9million shares just today 👀, simply does not explain the price action point for this week at all. Eccentric !

God(S) is Stonk

Mar 26 11:19

$Cartesian Therapeutics (RNAC.US)$ FMR had a top position in Viking Therapeutics, and here in Cartesian as well. The reverse split is to allow more institutions to follow suit. If you were to read the paper closely on the pipeline, their RNA cell therapy extends to a suite of autoimmune diseases. With a production up and coming, more partnership might be announced very soon.

Heat List

Overall

No Data